Over the next five years, Medisun plans to invest in five of China’s leading comprehensive and specialized hospitals/medical centers in Beijing, Shanghai, Chengdu, Xi’an, and Guangzhou. The total investment capital is expected to exceed CNY 10 billion. In collaboration with experts in these prestigious hospitals and medical centers, Medisun will develop and introduce the most advanced stem cell therapies and other biological products, and provide patients with unparalleled treatment options and care.
News 
Market Data 
Discover 
